International Stem Cell (ISCO) Cash & Equivalents (2016 - 2025)
Historic Cash & Equivalents for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to $966000.0.
- International Stem Cell's Cash & Equivalents fell 2609.03% to $966000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $966000.0, marking a year-over-year decrease of 2609.03%. This contributed to the annual value of $1.2 million for FY2024, which is 2254.41% down from last year.
- According to the latest figures from Q3 2025, International Stem Cell's Cash & Equivalents is $966000.0, which was down 2609.03% from $920000.0 recorded in Q2 2025.
- In the past 5 years, International Stem Cell's Cash & Equivalents ranged from a high of $1.6 million in Q4 2023 and a low of $171000.0 during Q4 2021
- Moreover, its 5-year median value for Cash & Equivalents was $966000.0 (2025), whereas its average is $991000.0.
- As far as peak fluctuations go, International Stem Cell's Cash & Equivalents crashed by 7518.14% in 2021, and later skyrocketed by 33391.81% in 2022.
- Over the past 5 years, International Stem Cell's Cash & Equivalents (Quarter) stood at $171000.0 in 2021, then surged by 333.92% to $742000.0 in 2022, then soared by 114.02% to $1.6 million in 2023, then fell by 22.54% to $1.2 million in 2024, then decreased by 21.46% to $966000.0 in 2025.
- Its Cash & Equivalents stands at $966000.0 for Q3 2025, versus $920000.0 for Q2 2025 and $1.5 million for Q1 2025.